Most recent lymphocyte subpopulations in JAK3-deficient patients after transplantation
. | Time of study* . | CD3+ cells . | . | . | . | . | CD20+ cells . | CD16+ cells . | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
. | . | Total . | CD4+ . | CD8+ . | CD45RA+ . | CD45RO+ . | . | . | ||||
Patient no. | ||||||||||||
1 | 3 | 7466 | 5097 | 2163 | 5793 | 732 | 746 | 49 | ||||
2 | 18 | 1450 | 766 | 552 | 1351 | 635 | 270 | 52 | ||||
3 | 12 | 3385 | 1353 | 1626 | 1642 | 721 | 1018 | 54 | ||||
4 | 4 | 1628 | 513 | 1115 | 620 | 485 | 771 | 114 | ||||
5 | 10 | 1512 | 529 | 897 | 869 | 357 | 638 | 319 | ||||
6 | 8 | 926 | 339 | 490 | 212 | 377 | 196 | 58 | ||||
8 | 10 | 1006 | 292 | 421 | 355 | 313 | 124 | 89 | ||||
9 | 9 | 669 | 137 | 338 | 203 | 191 | 237 | 103 | ||||
10 | 7 | 503 | 134 | 186 | 80 | 171 | 244 | 88 | ||||
Mean ± SD | 9 ± 4 | 2060 ± 2196 | 1018 ± 1575 | 865 ± 662 | 1236 ± 1792 | 442 ± 213 | 471 ± 323 | 103 ± 84 | ||||
Normal† | NA | 1014 ± 5784 | 567-3725 | 390-2673 | 543-2523 | 527-2461 | 121-1072 | 87-1189 |
. | Time of study* . | CD3+ cells . | . | . | . | . | CD20+ cells . | CD16+ cells . | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
. | . | Total . | CD4+ . | CD8+ . | CD45RA+ . | CD45RO+ . | . | . | ||||
Patient no. | ||||||||||||
1 | 3 | 7466 | 5097 | 2163 | 5793 | 732 | 746 | 49 | ||||
2 | 18 | 1450 | 766 | 552 | 1351 | 635 | 270 | 52 | ||||
3 | 12 | 3385 | 1353 | 1626 | 1642 | 721 | 1018 | 54 | ||||
4 | 4 | 1628 | 513 | 1115 | 620 | 485 | 771 | 114 | ||||
5 | 10 | 1512 | 529 | 897 | 869 | 357 | 638 | 319 | ||||
6 | 8 | 926 | 339 | 490 | 212 | 377 | 196 | 58 | ||||
8 | 10 | 1006 | 292 | 421 | 355 | 313 | 124 | 89 | ||||
9 | 9 | 669 | 137 | 338 | 203 | 191 | 237 | 103 | ||||
10 | 7 | 503 | 134 | 186 | 80 | 171 | 244 | 88 | ||||
Mean ± SD | 9 ± 4 | 2060 ± 2196 | 1018 ± 1575 | 865 ± 662 | 1236 ± 1792 | 442 ± 213 | 471 ± 323 | 103 ± 84 | ||||
Normal† | NA | 1014 ± 5784 | 567-3725 | 390-2673 | 543-2523 | 527-2461 | 121-1072 | 87-1189 |